PCa Commentary | Volume 151 – March 2021
This Commentary will addresses the guidance from four clinical trials regarding patient selection and imaging choices to best select patients most likely to benefit from MDT.
Read More
Articles by Greg Donohue
PCa Commentary | Volume 147 – November 2020
This Commentary discusses how olaparib and rucaparib offer a needed additional treatment option for men with mCRPC.
Read More
Diet, Exercise + Prostate Cancer
Diet, Exercise + Prostate Cancer This interview, “Diet, Exercise + Prostate Cancer,”...
Read More
Radiation, Immunotherapy + the Abscopal Effect
Radiation, Immunotherapy + the Abscopal Effect This interview, “Radiation, Immunotherapy +...
Read More
Surgery for Recurrent Prostate Cancer
Surgery for Recurrent Prostate Cancer This interview, “Surgery for Recurrent Prostate...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan